# Immuron Ltd: financial statements, quarterly

IMRN · Nasdaq · CIK 1660046 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/imrn.md) · [Financials](/companies/imrn/financials.md) · [Filings](/companies/imrn/filings.md) · [Insiders](/companies/imrn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/imrn/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2023 (2023-06-30) | FY2024 (2024-06-30) |
| --- | --- | ---: | ---: |
| Cash and equivalents | $k | [4,771](/filings/0001213900-24-083654.md) | [2,722](/filings/0001213900-24-083654.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents

Shares outstanding: 322,848,081 at 2026-06-30, from the cover of the [20-F filed 2026-09-24](/filings/0001213900-26-102838.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.